1. Home
  2. QNCX vs GEOS Comparison

QNCX vs GEOS Comparison

Compare QNCX & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • GEOS
  • Stock Information
  • Founded
  • QNCX 2012
  • GEOS 1980
  • Country
  • QNCX United States
  • GEOS United States
  • Employees
  • QNCX N/A
  • GEOS N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • GEOS Industrial Machinery/Components
  • Sector
  • QNCX Health Care
  • GEOS Industrials
  • Exchange
  • QNCX Nasdaq
  • GEOS Nasdaq
  • Market Cap
  • QNCX 85.9M
  • GEOS 72.9M
  • IPO Year
  • QNCX 2019
  • GEOS 1997
  • Fundamental
  • Price
  • QNCX $1.60
  • GEOS $17.21
  • Analyst Decision
  • QNCX Strong Buy
  • GEOS
  • Analyst Count
  • QNCX 6
  • GEOS 0
  • Target Price
  • QNCX $8.00
  • GEOS N/A
  • AVG Volume (30 Days)
  • QNCX 124.9K
  • GEOS 191.3K
  • Earning Date
  • QNCX 11-12-2025
  • GEOS 08-07-2025
  • Dividend Yield
  • QNCX N/A
  • GEOS N/A
  • EPS Growth
  • QNCX N/A
  • GEOS N/A
  • EPS
  • QNCX N/A
  • GEOS N/A
  • Revenue
  • QNCX N/A
  • GEOS $115,527,000.00
  • Revenue This Year
  • QNCX N/A
  • GEOS N/A
  • Revenue Next Year
  • QNCX N/A
  • GEOS N/A
  • P/E Ratio
  • QNCX N/A
  • GEOS N/A
  • Revenue Growth
  • QNCX N/A
  • GEOS N/A
  • 52 Week Low
  • QNCX $0.69
  • GEOS $5.51
  • 52 Week High
  • QNCX $2.45
  • GEOS $21.60
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 47.89
  • GEOS 51.03
  • Support Level
  • QNCX $1.56
  • GEOS $16.10
  • Resistance Level
  • QNCX $1.65
  • GEOS $17.29
  • Average True Range (ATR)
  • QNCX 0.07
  • GEOS 1.34
  • MACD
  • QNCX 0.00
  • GEOS -0.41
  • Stochastic Oscillator
  • QNCX 64.65
  • GEOS 29.45

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

Share on Social Networks: